Author name: Oscar Ting

Translatomics for RACK1, FAK and NAT10

August 17th, 2025 Recent Publications Harnessing the Power of Translatomics Every week we provide a digest of a small number of recent interesting papers in the field of translatomics. In this week’s Sunday papers, Challa et al. highlight that MARylation of ribosomal protein RACK1 functions as a key regulator of stress granule formation. Kellett et […]

Translatomics for RACK1, FAK and NAT10 Read More »

Translatomics for proline, eIF6 and neoantigen

August 10th, 2025 Recent Publications Harnessing the Power of Translatomics Every week we provide a digest of a small number of recent interesting papers in the field of translatomics. In this week’s Sunday papers, Reepmeyer et al. study that substituting Api137’s prolines with 4-fluoro-l-proline altered ribosome binding and activity. Roshan et al. investigate that targeting

Translatomics for proline, eIF6 and neoantigen Read More »

Translatomics for micropeptides and antigens

August 3rd, 2025 Recent Publications Harnessing the Power of Translatomics Every week we provide a digest of a small number of recent interesting papers in the field of translatomics. In this week’s Sunday papers, Xu et al. identify that a LINC00472-derived micropeptide suppresses non‑small cell lung cancer (NSCLC) proliferation and migration by disrupting HDAC2/SP1 interaction.

Translatomics for micropeptides and antigens Read More »

Translatomics for cancer immunity and translation

July 27th, 2025 Recent Publications Harnessing the Power of Translatomics Every week we provide a digest of a small number of recent interesting papers in the field of translatomics. In this week’s Sunday papers, Susanto et al. introduce RAPIDASH, a tag-free method to profile ribosome-associated proteins, uncovering dynamic changes in translation machinery across embryonic tissues,

Translatomics for cancer immunity and translation Read More »

Translatomics for m6A, adipocyte and anemia

July 20th, 2025 Recent Publications Harnessing the Power of Translatomics Every week we provide a digest of a small number of recent interesting papers in the field of translatomics. In this week’s Sunday papers, Zuidhof et al. demonstrate the influence of FTO on C/EBPβ‐LIP translation, impacting on downstream breast cancer dynamics. Youn et al. uncover

Translatomics for m6A, adipocyte and anemia Read More »

Translatomics for neuronal aging, eIF3, and heat shock

July 13th, 2025 Recent Publications Harnessing the Power of Translatomics Every week we provide a digest of a small number of recent interesting papers in the field of translatomics. In this week’s Sunday papers, Rhine et al. find that neuronal aging leads to mislocalization of RNA-binding proteins, dysfunctional stress granules, and impaired translation. Mestre-Fos et

Translatomics for neuronal aging, eIF3, and heat shock Read More »

Translatomics for placentas, embryos, and C. reinhardtii

July 6th, 2025 Recent Publications Harnessing the Power of Translatomics Every week we provide a digest of a small number of recent interesting papers in the field of translatomics. In this week’s Sunday papers, Zhao et al. use ribosome profiling to explore the translation of circRNAs in the placenta and to uncover the potential roles

Translatomics for placentas, embryos, and C. reinhardtii Read More »

Translatomics for colorectal cancer

June 29th, 2025 Recent Publications Harnessing the Power of Translatomics Every week we provide a digest of a small number of recent interesting papers in the field of translatomics. In this week’s Sunday papers, Schwarzmueller et al. underscored the function of ribosome profiling analysis to distinguish functional lncRNAs from misannotated coding transcripts and to uncover

Translatomics for colorectal cancer Read More »

Translatomics for prostate cancer, obesity and diabetes

June 15th, 2025 Recent Publications Harnessing the Power of Translatomics Every week we provide a digest of a small number of recent interesting papers in the field of translatomics. In this week’s Sunday papers, Kuzuoglu-Ozturk et al. discovered that targeting RNA structures with small molecules like zotatifin offers a novel therapeutic strategy for castration-resistant prostate

Translatomics for prostate cancer, obesity and diabetes Read More »

Scroll to Top